Fusion Family Wealth LLC Eli Lilly & CO Transaction History

Fusion Family Wealth LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $23,375 - $27,514	-210 Closed	0 $0
Q4 2018 Jan 18, 2019	BUY	$105.9 - $118.64 $105 - $118	1 Added 0.48%	210 $24,000
Q3 2018 Nov 07, 2018	BUY	$85.86 - $107.31 $85 - $107	1 Added 0.48%	209 $22,000
Q2 2018 Aug 03, 2018	BUY	$75.7 - $86.88 $75 - $86	1 Added 0.48%	208 $18,000
Q1 2018 May 02, 2018	SELL	$74.21 - $87.6 $14,693 - $17,344	-198 Reduced 48.89%	207 $16,000
Q4 2017 Feb 06, 2018	BUY	$81.94 - $87.89 $16,797 - $18,017	205 Added 102.5%	405 $34,000
Q3 2017 Oct 30, 2017	SELL	$77.07 - $85.54 $231 - $256	-3 Reduced 1.48%	200 $17,000
Q2 2017 Aug 07, 2017	BUY	N/A	203	203 $17,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Fusion Family Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Fusion Family Wealth LLC with notifications on news.